Ho Chang-Han, Tsai Cheng-Yu, Chang Chi-Chieh, Hu Chin-Ju, Huang Cheng-Yen, Lu Ying-Chang, Lin Pei-Hsuan, Lin Chin-Hsien, Lin Han-I, OuYang Chih-Hsin, Hsu Chuan-Jen, Liu Tien-Chen, Chen You-Tzung, Chan Yen-Hui, Cheng Yen-Fu, Wu Chen-Chi
Department of Otolaryngology-Head and Neck Surgery, National Taiwan University Hospital, Taipei 100225, Taiwan.
Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei 100233, Taiwan.
Int J Mol Sci. 2025 May 22;26(11):4980. doi: 10.3390/ijms26114980.
Recessive variants of are a common cause of hereditary hearing impairment and are responsible for non-syndromic enlarged vestibular aqueducts and Pendred syndrome. Patients with bi-allelic variants often suffer from fluctuating hearing loss and recurrent vertigo, ultimately leading to severe to profound hearing impairment. However, there are currently no satisfactory prevention or treatment options for this condition. The CRISPR/Cas9 genome-editing technique is a well-known tool for correcting point mutations or manipulating genes and shows potential therapeutic applications for hereditary disorders. In this study, we used the homology-independent targeted integration (HITI) strategy to correct the c.919-2A>G variant, the most common variant in the Han Chinese population. Next-generation sequencing was performed to evaluate the editing efficiency of the HITI strategy. The results showed that only 0.15% of the reads successfully exhibited HITI integration, indicating that the c.919-2 region may not be a suitable region for HITI selection. This suggests that other site selection or insertion strategies may be needed to improve the efficiency of correcting the c.919-2A>G variant. This experience may serve as a valuable reference for other researchers considering CRISPR target design in this region.
的隐性变异是遗传性听力损失的常见原因,可导致非综合征性大前庭导水管和 Pendred 综合征。双等位基因变异的患者常患有波动性听力损失和复发性眩晕,最终导致重度至极重度听力损失。然而,目前针对这种情况尚无令人满意的预防或治疗方案。CRISPR/Cas9 基因组编辑技术是一种用于纠正点突变或操纵基因的知名工具,对遗传性疾病显示出潜在的治疗应用价值。在本研究中,我们使用同源性独立靶向整合(HITI)策略纠正了 c.919-2A>G 变异,这是汉族人群中最常见的变异。通过下一代测序评估 HITI 策略的编辑效率。结果显示,仅 0.15% 的读数成功显示 HITI 整合,表明 c.919-2 区域可能不是 HITI 选择的合适区域。这表明可能需要其他位点选择或插入策略来提高纠正 c.919-2A>G 变异的效率。这一经验可为其他考虑在该区域进行 CRISPR 靶点设计的研究人员提供有价值的参考。